Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

34 filings reported holding ACHL - Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share as of Q2 2024.
Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 22.2M shares of 41.1M outstanding shares and own 53.96% of the company stock.
Largest 10 shareholders include Syncona Portfolio Ltd (11.1M shares), FCPM III SERVICES B.V. (2.39M shares), Redmile Group, LLC (1.61M shares), Vestal Point Capital, LP (1.5M shares), Ikarian Capital, LLC (1.44M shares), BAKER BROS. ADVISORS LP (1.11M shares), Artal Group S.A. (755K shares), RENAISSANCE TECHNOLOGIES LLC (683K shares), BML Capital Management, LLC (625K shares), and BOOTHBAY FUND MANAGEMENT, LLC (420K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.